{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T05:37:43Z","timestamp":1768628263382,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,25]]},"DOI":"10.1093\/infdis\/jiy123","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T04:11:14Z","timestamp":1519963874000},"page":"1957-1966","source":"Crossref","is-referenced-by-count":37,"title":["Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model"],"prefix":"10.1093","volume":"217","author":[{"given":"Markus H","family":"Kainulainen","sequence":"first","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R","family":"Spengler","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R","family":"Welch","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn D","family":"Coleman-McCray","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R","family":"Harmon","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Klena","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart T","family":"Nichol","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar G","family":"Albari\u00f1o","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina F","family":"Spiropoulou","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"key\n\t\t\t\t20180626074843_CIT0001","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","article-title":"Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings","volume":"19","author":"Frame","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180626074843_CIT0002","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4269\/ajtmh.1970.19.677","article-title":"Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease","volume":"19","author":"Leifer","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180626074843_CIT0003","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4269\/ajtmh.1970.19.692","article-title":"Lassa fever, a new virus disease of man from West Africa. IV. Electron microscopy of Vero cell cultures infected with Lassa virus","volume":"19","author":"Speir","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180626074843_CIT0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.185.4147.263","article-title":"Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone","volume":"185","author":"Monath","year":"1974","journal-title":"Science"},{"key":"key\n\t\t\t\t20180626074843_CIT0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4269\/ajtmh.1974.23.1131","article-title":"Lassa fever in the Eastern province of Sierra Leone, 1970\u20131972. I. Epidemiologic studies","volume":"23","author":"Fraser","year":"1974","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180626074843_CIT0006","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074843_CIT0007","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4269\/ajtmh.1974.23.1140","article-title":"Lassa fever in the Eastern province of Sierra Leone, 1970\u20131972. II. Clinical observations and virological studies on selected hospital cases","volume":"23","author":"Monath","year":"1974","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20180626074843_CIT0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1863-2378.2012.01469.x","article-title":"Lassa fever in West Africa: evidence for an expanded region of endemicity","volume":"59","author":"Sogoba","year":"2012","journal-title":"Zoonoses Public Health"},{"key":"key\n\t\t\t\t20180626074843_CIT0009","volume-title":"WHO target product profile for Lassa virus vaccine","author":"World Health Organization","year":"2017"},{"key":"key\n\t\t\t\t20180626074843_CIT0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074843_CIT0011","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/JVI.02556-10","article-title":"Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence","volume":"85","author":"Albari\u00f1o","year":"2011","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0012","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nature09605","article-title":"Cap binding and immune evasion revealed by Lassa nucleoprotein structure","volume":"468","author":"Qi","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180626074843_CIT0013","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1073\/pnas.1016404108","article-title":"Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3\u2019 to 5\u2019 exonuclease activity essential for immune suppression","volume":"108","author":"Hastie","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180626074843_CIT0014","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1099\/0022-1317-72-3-549","article-title":"Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies","volume":"72","author":"Ruo","year":"1991","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0015","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20180626074843_CIT0016","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/dnares\/dsu029","article-title":"The genome landscape of the African green monkey kidney-derived vero cell line","volume":"21","author":"Osada","year":"2014","journal-title":"DNA Res"},{"key":"key\n\t\t\t\t20180626074843_CIT0017","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1091\/mbc.e07-04-0374","article-title":"Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell","volume":"18","author":"Rojek","year":"2007","journal-title":"Mol Biol Cell"},{"key":"key\n\t\t\t\t20180626074843_CIT0018","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.170.6.2797","article-title":"Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses","volume":"170","author":"Mahanty","year":"2003","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180626074843_CIT0019","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.172.5.2861","article-title":"Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells","volume":"172","author":"Baize","year":"2004","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180626074843_CIT0020","doi-asserted-by":"crossref","first-page":"12696","DOI":"10.1128\/JVI.00882-07","article-title":"Differential inhibition of type I interferon induction by arenavirus nucleoproteins","volume":"81","author":"Mart\u00ednez-Sobrido","year":"2007","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0021","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1128\/JVI.03349-14","article-title":"The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production","volume":"89","author":"Xing","year":"2015","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0022","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1128\/JVI.01362-09","article-title":"Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction","volume":"84","author":"Fan","year":"2010","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0023","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1128\/JVI.00429-11","article-title":"Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages","volume":"85","author":"Carnec","year":"2011","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0024","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/iai.37.2.771-778.1982","article-title":"Pathogenesis of Lassa virus infection in guinea pigs","volume":"37","author":"Jahrling","year":"1982","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180626074843_CIT0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/0300985816677153","article-title":"Temporal progression of lesions in guinea pigs infected with Lassa virus","volume":"54","author":"Bell","year":"2017","journal-title":"Vet Pathol"},{"key":"key\n\t\t\t\t20180626074843_CIT0026","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0027","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0028","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant yellow fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"Bredenbeek","year":"2006","journal-title":"Virology"},{"key":"key\n\t\t\t\t20180626074843_CIT0029","doi-asserted-by":"crossref","first-page":"e0003736","DOI":"10.1371\/journal.pntd.0003736","article-title":"A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses","volume":"9","author":"Safronetz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180626074843_CIT0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/vaccines1030262","article-title":"Enhanced efficacy of a codon-optimized DNA vaccine encoding the glycoprotein precursor gene of Lassa virus in a guinea pig disease model when delivered by dermal electroporation","volume":"1","author":"Cashman","year":"2013","journal-title":"Vaccines (Basel)"},{"key":"key\n\t\t\t\t20180626074843_CIT0031","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jmv.1890120203","article-title":"Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin","volume":"12","author":"Jahrling","year":"1983","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0032","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2011.02.012","article-title":"Evaluation of Lassa antiviral compound ST-193 in a guinea pig model","volume":"90","author":"Cashman","year":"2011","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20180626074843_CIT0033","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1128\/JVI.00896-06","article-title":"Identification of protective Lassa virus epitopes that are restricted by HLA-A2","volume":"80","author":"Botten","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0034","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1743-422X-7-279","article-title":"Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever","volume":"7","author":"Branco","year":"2010","journal-title":"Virol J"},{"key":"key\n\t\t\t\t20180626074843_CIT0035","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0264-410X(99)00439-9","article-title":"Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein","volume":"18","author":"Djavani","year":"2000","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074843_CIT0036","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virol.2016.11.001","article-title":"Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein","volume":"501","author":"Cheng","year":"2017","journal-title":"Virology"},{"key":"key\n\t\t\t\t20180626074843_CIT0037","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1080\/21645515.2017.1356500","article-title":"A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever","volume":"13","author":"Cashman","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180626074843_CIT0038","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(87)90767-7","article-title":"Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever","volume":"2","author":"Clegg","year":"1987","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626074843_CIT0039","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-1702(88)90033-0","article-title":"Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection","volume":"9","author":"Auperin","year":"1988","journal-title":"Virus Res"},{"key":"key\n\t\t\t\t20180626074843_CIT0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0042-6822(89)90525-4","article-title":"Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus","volume":"171","author":"Morrison","year":"1989","journal-title":"Virology"},{"key":"key\n\t\t\t\t20180626074843_CIT0041","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for lassa fever","volume":"74","author":"Fisher-Hoch","year":"2000","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0042","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180626074843_CIT0043","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1016\/j.vaccine.2008.07.057","article-title":"Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates","volume":"26","author":"Lukashevich","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074843_CIT0044","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/JVI.78.6.2979-2983.2004","article-title":"Cells expressing the RING finger Z protein are resistant to arenavirus infection","volume":"78","author":"Cornu","year":"2004","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0045","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/JVI.00074-09","article-title":"Replication-deficient ebolavirus as a vaccine candidate","volume":"83","author":"Halfmann","year":"2009","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0046","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaa4919","article-title":"Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates","volume":"348","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"key\n\t\t\t\t20180626074843_CIT0047","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/JVI.07104-11","article-title":"Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge","volume":"86","author":"Dodd","year":"2012","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0048","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1128\/JVI.00841-11","article-title":"Creation of a nonspreading Rift Valley fever virus","volume":"85","author":"Kortekaas","year":"2011","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074843_CIT0049","volume-title":"WHO publishes list of top emerging diseases likely to cause major epidemics","author":"World Health Organization","year":"2015"},{"key":"key\n\t\t\t\t20180626074843_CIT0050","volume-title":"Global partnership launched to prevent epidemics with new vaccines","author":"Coalition for Epidemic Preparedness Innovations","year":"2017"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/217\/12\/1957\/25090688\/jiy123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T03:36:08Z","timestamp":1660534568000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/217\/12\/1957\/4923216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,3,6]]},"published-print":{"date-parts":[[2018,5,25]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy123","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6,15]]},"published":{"date-parts":[[2018,3,6]]}}}